Prevalence assessment
OtherAssessment of the prevalence of rosacea in the general population per country using subject questionnaire and dermatologist diagnosis
NCT Number: NCT02292797
Multi-centre interventional cross-sectional prevalence study Assessment of the Rosacea Prevalence in the General Population.
Looking for future studies?
Notify Me18 year–65 year
All sexes
Observational
Primary objective:
Assessment of the prevalence of rosacea in the general population per country using subject questionnaire and dermatologist diagnosis
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Part I
Inclusion criteria
The following subjects will be included in the study:
Part II
Inclusion criteria
The following subjects will be included in Part II of the study:
Assessment of the prevalence of rosacea in the general population per country using subject questionnaire and dermatologist diagnosis
Time frame: general population will be surveyed over an expected average duration of 6 months
estimation of the percentage of rosacea patients in the general population
Galderma R&D
Industry
Assessment of the Prevalence of Rosacea in the General Population
Acronym: RISE
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07729540
Erythema, Pathological Conditions, Signs and Symptoms
Sosnowiec, Poland
View Trial DetailsNCT07606820
Rosacea, Skin Diseases
Nanjing, Jiangsu, China
View Trial DetailsNCT04886739
Rosacea, Skin Diseases
Fremont, California, United States
View Trial DetailsNCT04275999
Rosacea, Skin Diseases
Winston-Salem, North Carolina, United States
View Trial Details